Cargando…
Introduction
BACKGROUND: The Patient Protection and Affordable Care Act brought considerable attention to comparative effectiveness research (CER). OBJECTIVES: To (a) suggest best practices for conducting and reporting CER using “real-world data” (RWD), (b) describe some of the data and infrastructure requirem...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442892/ http://dx.doi.org/10.18553/jmcp.2011.17.s9-a.S03 |